Collegium Pharmaceutical (COLL) and Paris Hilton are collaborating to share her personal experience living with attention-deficit/hyperactivity disorder, ADHD, and her treatment journey. Through this collaboration, Paris aims to reduce stigma and encourage others living with ADHD to speak with their healthcare provider about finding a treatment plan that works best for them.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL: